Member Info for eshaitan

Well I got my hands on as much as I could this morning under 1.5p. It's a gamble but any hint of good consistent grades and this will fly.

I wonder what has caused the recent drop? I have kept my eye in this for some time, amazed that this dog has still limped on. But I have to say the new CEO is really getting stuff moving, and I'm thinking of buying some tomorrow. He has a good track record and it's good to finally see them drilling. If anyone is going to turn this around this team will.

I'm not sure cookie. 4 million in revenues but just 20k of profit. thats half of 1pc margin. It's basically selling at cost price. 2.5 million in the first quarter is great, but again at what level of profit? Break even seems a long way off.

Cash outflow was 150k in June. At the end of May it was 0.68 million. End June 0.97 million with 440k borrowed. I think they lost In average 300k per month in the first 5 months. Which suggests the 3 year India block deal has put a big dent in outflow of cash. It seems to me they don't need many more deals to be break even with plenty of territories yet to exploit and more from India to come as well. Hopefully fox will learn to stop relying on small distributors, at least never on credit terms, it has never gone well. Stick with the large companies that pay up front and order big.

One of those things, outside of their control. A couple of quick points, they have only really impaired nearly 70k they are owed. They have done the sensible thing and taken them off the order book until it is resolved. Think about it. Pisani really only put fox marble in touch with large developments in the uk. Fox marble are sure to contact those developers directly and arrange the deal to continue, this time with no commission to a middle man. A bit more legwork yes, but a cost to the company? I doubt it. Positive news, cash didn't diminish in July. They can break even on a month to month basis. Nothing has changed, a short term knock but expect the deals to come rolling in and that order book increase.

Nice to see this finally resolved. Hopefully you will make a nice wad of money today.

Qd22, it's really worth going through the numbers on the reports, especially the notes included at the bottom where anything nasty can be hidden away from headline numbers. For instance from memory cash at 31st December 2016 was around 900,000 euros, and towards the end of May 2017 it was reported to be just under 700,000 euros. That looks great, minimal cash burn, especially as the whole operation gets shut down for at least 2 months each year due to snow. You dig deeper though and in the notes it tells you they entered into a 500,000 pounds loan in February 2017 and VAT got repaid from the Kosovan government in March to the tune of 600,000 euros. From that you can deduce the cash burn in the first 5 months this year was around 1.5 million euros. Normally I wouldn't invest on that information as it looks like a recipe for an imminent placing but they are now creditworthy and have been able to raise an additional 1 million pounds debt facility at 9pc. This with the money in the bank gives them enough working capital to get through to November with zero sales, if you assume cash burn stays around the 4 million euros level recorded in 2016. But I think sales should ramp up pretty quickly now and on a month by month basis over the next few months they should be getting near cash flow neutral and into profit. The way I see it cash burn is about 300,000 - 350,000 euro's per month. It might be less as quarrying costs reduce this year but there will be an increase in factory costs to balance any savings. I think they need to be hitting 600,000-700,000 euro's per month of revenues to break even. It's hard to judge as it's impossible to predict the ratio of sales from blocks and slabs, but with the broker forecasting 5.8 million euro's of sales this year and that India deal worth around 150,000 euro's of revenue per month up front by itself I think the ramp up of sales in h2 to be pretty spectacular. H1 revenues I don't think will be that great but the forward looking statement should be. Another plus is they have said the factory will be processing all 12 months of the year, no winter shutdown. That's where the money and high margins really is and will mean January and February aren't a big drain anymore. You're probably doing the right thing from a sensible investing perspective. The share price is 9p and the Mcap 16 million for a reason, it's a risk, and the management have not delivered in the past. Of course, if I'm right I will get the lion's share of the rewards. If I'm wrong another placing will have to happen by the end of the year and I'm going to take a beating. Either way it's a interesting one to watch from the sidelines.

I think they were released a while ago. They weren't great, about 800k revenues for the year, most of the year was spent getting the Malesheva quarry running at optimum levels and digging trenches. I have to hand it to the board though, they said they expected the illyric marbles to provide the bulk of future sales and it looks like they will. That and the sivec are going to be company makers. The link for company reports are below https://www.foxmarble.net/annual-interim-reports

They will be most welcome I'm surprised they said in the final results the delay for commissioning was down to them conserving cash ahead of sales. It makes you wonder how much of the Dino Marble order for slabs and tiles will actually be fulfilled in the short term. I have bought my full stake now, so hoping for an RNS soon on more block sales. That new customer RK Marble Pvt Ltd in India sounds promising.

Probably just boredom. I sold everything on the spike on initial reports, anyone that rushed to buy then really didjt understand just how unbelievably bad the Greek courts are at getting anything done. Could be a value play now but just don't want to get bogged down in this share indefinitely. It's too risky.

Thanks. I think the main difference now is the confidence they have in the companies they are supplying marble to. People that pay up front and others they have good history with. In the past too many deals have been announced which have not come to fruition. The China block deal and Eboracum slab deal for 2million euro's quite frankly shouldn't have been announced as orders until money was received up front. When they didn't come to fruition they alienated too many shareholders. Revenues are going to be weighted to the 2nd half with the quarries being closed Jan and Feb but I hope they at least get revenues of 1 million euro's in h1. I'm pretty sure with minimal slabs being supplied they won't even break even this year, but as long as there is no dilution and they are profitable from next year I'm happy. I see our sivec neighbour had sales of 5million euro's and profits of 1.5 million after all costs in the first quarter this year, that's the sort of sales we eventually want to see. http://www.mermeren.com/investor_relation.html

I like your optimism. I'm still not happy that the factory isn't fully functional, I'm sure it has been announced "shortly" about ten times now over the years. But, I'm willing to believe they are selling enough blocks now to at least put a big break on the cash flowing out. I bought 8k's worth today and will start to build a bigger stake next week. It's quite possible more sales will be announced which will push the order book higher this year and if there is any slippage on other contracts that will balance it out. I can see quite a bit of news flow over the coming months. I could be very wrong, history definitely doesn't support it, but this is looking far less risky than most shares out there. I still like the story of a low cost base and high margins, it's a business that makes sense.

released this morning and is on share prophets, with revised revenues for the next 3 years. They are now forecasting 1.3million in revenues this year giving a 2 million loss and 6 million revenues next year equating to a 840k profit. Target price 22p.

I got 2 lots of 5k buys in this morning. The average down continues.

Alan Reynolds said in his last interview they have enough cash unless they want to do something big in Europe. There have been delays, but the company has said the cash position year end will still be as expected. I suppose it depends how much advertising and how much stock they wish to produce in advance of a uk/eu launch. It's possible they may use any spike in share price to strengthen the balance sheet, but I don't think we will see it this year if at all. It will be interesting to see how china progresses. Hz biotech now have to manufacture the devices, the uk provides the strips. I wonder if they was to stop counterfeiting? Sentiment will turn, I agree the Mcap looks silly.

Thanks researcher, much appreciated. I had a quick reevaluation of the company last night to see if the fundamentals have changed since the delays. I disregarded the possible chronic stress spin off, even though different strips would be able to be used on the meter, and concentrated just on the fertility product. The company were originally hoping to break even by the end of this year at the latest on a month by month basis, I think that has been pushed back to mid next year now as both China and the UK are slightly behind in sales through delays on trials and obtaining the CE mark. The China delay has been blown out of proportion, it was going to be far more difficult to crack this market than the UK or EU, but it will happen. A 225,000 pounds initial order is a statement of intent. The vast majority of EU and UK sales will be done online, expect mylotus to be advertised for sale within days of receiving the CE mark from the regulators. China they can't access the online route just now as only a handful of pharmacies have licences to trade online within China so they have had to go down the hospital and distributor route which takes far more effort. The next 6 months should be sustained good news, with more distributors signed up, reoccurring sales from HZ Biotech and of course the CE mark and the launch of mylotus online. I personally think UK/EU sales will dwarf Chinese ones. The 40pc fall in the share price with the last 4 months doesn't make sense, progress in the last year has been fast, and now it's about to get faster. I can't add any more money to my Uk share dealing accounts now I am non resident and have had to sell shares in other companies to average down but I'm going to buy some on my international account here. I think these look very very cheap.

Thank you. I'm in no rush to sell. I feel much more comfortable seeing a large order come in as well. I topped up a couple of days ago, I should have waited, but that's life!

Or not! Sod it that's 30pc down. Back to the holiday.

It should be fine. I think investors will just be glad to get started. No mention that hospital trials have definitely concluded though. I expect share prophets will retip this again today. They need 20 or 30 distributors to cover China and this one has put in quite a substantial initial order. In my mind they only need revenues of a few million to break even, and then gearing takes effect. The hard bit is putting the whole network together to get the company there.

researcher1, if you do go could you please ask the approximate profit margin on each unit and how many they think they need to sell per annum to break even? I remember when I was making Advair for GSK the cost of production was miniscule. I should think that will be the case here, I'm more interested in what margin the distributors take. Thanks, I wish I could make it myself.